Items where Author is "McBain, Catherine"

Article

van den Bent, Martin J. and Tesileanu, C. Mircea S. and Wick, Wolfgang and Sanson, Marc and Brandes, Alba Ariela and Clement, Paul M. and Erridge, Sarah and Vogelbaum, Michael A. and Nowak, Anna K. and Baurain, Jean Francais and Mason, Warren P. and Wheeler, Helen and Chinot, Olivier L. and Gill, Sanjeev and Griffin, Matthew and Rogers, Leland and Taal, Walter and Ruda, Roberta and Weller, Michael and McBain, Catherine and Reijneveld, Jaap and Enting, Roelien H. and Caparrotti, Francesca and Lesimple, Thierry and Clenton, Susan and Gijtenbeek, Anja and Lim, Elizabeth and Herrlinger, Ulrich and Hau, Peter and Dhermain, Frederic and de Heer, Iris and Aldape, Kenneth and Jenkins, Robert B. and Dubbink, Hendrikus Jan and Kros, Johan M. and Wesseling, Pieter and Nuyens, Sarah and Golfinopoulos, Vassilis and Gorlia, Thierry and French, Pim and Baumert, Brigitta G. (2021) Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. LANCET ONCOLOGY, 22 (6). pp. 813-823. ISSN 1470-2045, 1474-5488

van den Bent, Martin J. and Baumert, Brigitta and Erridge, Sara C. and Vogelbaum, Michael A. and Nowak, Anna K. and Sanson, Marc and Brandes, Alba Ariela and Clement, Paul M. and Baurain, Jean Francais and Mason, Warren P. and Wheeler, Helen and Chinot, Olivier L. and Gill, Sanjeev and Griffin, Matthew and Brachman, David G. and Taal, Walter and Ruda, Roberta and Weller, Michael and McBain, Catherine and Reijneveld, Jaap and Enting, Roelien H. and Weber, Damien C. and Lesimple, Thierry and Clenton, Susan and Gijtenbeek, Anja and Pascoe, Sarah and Herrlinger, Ulrich and Hau, Peter and Dhermain, Frederic and van Heuvel, Irene and Stupp, Roger and Aldape, Ken and Jenkins, Robert B. and Dubbink, Hendrikus Jan and Dinjens, Winand N. M. and Wesseling, Pieter and Nuyens, Sarah and Golfinopoulos, Vassilis and Gorlia, Thierry and Wick, Wolfgang and Kros, Johan M. (2017) Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. LANCET, 390 (10103). pp. 1645-1653. ISSN 0140-6736, 1474-547X

Stupp, Roger and Hegi, Monika E. and Gorlia, Thierry and Erridge, Sara C. and Perry, James and Hong, Yong-Kil and Aldape, Kenneth D. and Lhermitte, Benoit and Pietsch, Torsten and Grujicic, Danica and Steinbach, Joachim Peter and Wick, Wolfgang and Tarnawski, Rafal and Nam, Do-Hyun and Hau, Peter and Weyerbrock, Astrid and Taphoorn, Martin J. B. and Shen, Chiung-Chyi and Rao, Nalini and Thurzo, Laszlo and Herrlinger, Ulrich and Gupta, Tejpal and Kortmann, Rolf-Dieter and Adamska, Krystyna and McBain, Catherine and Brandes, Alba A. and Tonn, Joerg Christian and Schnell, Oliver and Wiegel, Thomas and Kim, Chae-Yong and Nabors, Louis Burt and Reardon, David A. and van den Bent, Martin J. and Hicking, Christine and Markivskyy, Andriy and Picard, Martin and Weller, Michael (2014) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial. LANCET ONCOLOGY, 15 (10). pp. 1100-1108. ISSN 1470-2045, 1474-5488